tradingkey.logo
tradingkey.logo
Search

Biodesix Inc

BDSX
Add to Watchlist
22.000USD
-0.320-1.43%
Close 07-24 16:00ETQuotes delayed by 15 min
227.83MMarket Cap
LossP/E TTM

BDSX Income Statement

You can find the annual or quarterly income statement of Biodesix Inc here for insights into the performance and operational efficiency of Biodesix Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
Total revenue
42.30%25.55M
40.76%28.75M
19.93%21.77M
11.68%20.02M
21.19%17.96M
39.28%20.43M
34.54%18.15M
50.99%17.93M
63.63%14.82M
52.68%14.67M
21.46%13.49M
8.42%11.87M
38.30%9.06M
32.99%9.61M
70.07%11.11M
-7.87%10.95M
-77.32%6.55M
-73.27%7.22M
-28.96%6.53M
--11.88M
--28.87M
--27.03M
--9.19M
Revenue
42.30%25.55M
40.76%28.75M
19.93%21.77M
11.68%20.02M
21.19%17.96M
39.28%20.43M
34.54%18.15M
50.99%17.93M
63.63%14.82M
52.68%14.67M
21.46%13.49M
8.42%11.87M
38.30%9.06M
32.99%9.61M
70.07%11.11M
-7.87%10.95M
-77.32%6.55M
-73.27%7.22M
-28.96%6.53M
--11.88M
--28.87M
--27.03M
--9.19M
Cost of revenue
13.56%4.21M
12.37%4.88M
-1.75%4.11M
3.97%4.03M
16.63%3.70M
28.69%4.34M
29.42%4.18M
19.73%3.88M
0.19%3.17M
2.06%3.37M
-11.12%3.23M
-18.64%3.24M
-2.04%3.17M
32.61%3.31M
33.47%3.63M
-43.82%3.98M
-82.24%3.23M
-82.99%2.49M
-30.04%2.72M
--7.08M
--18.22M
--14.65M
--3.89M
Operating expenses
17.50%31.75M
13.89%30.72M
7.74%28.81M
13.86%29.71M
4.85%27.02M
25.38%26.98M
29.42%26.74M
14.46%26.09M
1.42%25.77M
-8.44%21.51M
-4.85%20.66M
0.99%22.80M
21.41%25.41M
24.30%23.50M
10.68%21.72M
3.40%22.58M
-37.46%20.93M
-36.61%18.90M
35.55%19.62M
--21.83M
--33.47M
--29.82M
--14.48M
R&D expenses
14.46%3.29M
18.89%2.87M
17.47%2.99M
27.80%3.27M
40.69%2.87M
27.79%2.41M
31.42%2.55M
-12.10%2.56M
-37.25%2.04M
-47.01%1.89M
-34.75%1.94M
-13.42%2.91M
1.40%3.25M
25.00%3.56M
-9.81%2.97M
1.14%3.36M
-3.46%3.21M
-8.15%2.85M
21.69%3.29M
--3.32M
--3.32M
--3.10M
--2.71M
Depreciation, depletion, and amortization
-2.78%1.40M
-5.84%1.39M
-6.20%1.41M
1.70%1.44M
1.41%1.44M
50.77%1.47M
87.50%1.50M
76.50%1.41M
77.50%1.42M
8.80%977.00K
-11.11%800.00K
-11.11%800.00K
-11.89%800.00K
2.28%898.00K
12.50%900.00K
15.83%900.00K
13.50%908.00K
20.44%878.00K
2.17%800.00K
--777.00K
--800.00K
--729.00K
--783.00K
Other operating expenses
---25.55M
----
---21.77M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
31.63%-6.20M
69.97%-1.97M
18.01%-7.04M
-18.64%-9.69M
17.26%-9.06M
4.38%-6.55M
-19.79%-8.59M
25.23%-8.17M
33.02%-10.95M
50.71%-6.85M
32.40%-7.17M
6.01%-10.93M
-13.72%-16.35M
-18.93%-13.89M
18.95%-10.61M
-16.87%-11.63M
-212.61%-14.38M
-318.30%-11.68M
-147.79%-13.09M
---9.95M
---4.60M
---2.79M
---5.28M
Net non-operating interest income (expenses)
Non-operating interest income
--100.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--18.00K
----
Non-operating interest expense
17.33%1.98M
17.52%2.06M
1.62%2.07M
-1.96%1.90M
-33.37%1.69M
-24.77%1.75M
-14.46%2.04M
-20.33%1.94M
5.77%2.53M
-8.67%2.33M
-21.49%2.39M
80.53%2.43M
110.29%2.39M
70.45%2.55M
96.57%3.04M
65.15%1.35M
74.65%1.14M
112.20%1.50M
-41.84%1.55M
--815.00K
--651.00K
--705.00K
--2.66M
Special income (expenses)
98.89%-5.00K
99.03%-1.00K
---7.00K
122.86%72.00K
-563.24%-451.00K
-402.94%-103.00K
100.00%0.00
---315.00K
-265.85%-68.00K
100.87%34.00K
-2578.85%-1.39M
100.00%0.00
150.62%41.00K
-3913.40%-3.89M
-101.67%-52.00K
-361.97%-2.95M
95.27%-81.00K
91.28%-97.00K
426.33%3.12M
---639.00K
---1.71M
---1.11M
---957.00K
Other non-operating income (expenses)
190.82%285.00K
-69.33%46.00K
9.36%409.00K
113.18%51.00K
253.13%98.00K
7400.00%150.00K
18600.00%374.00K
-38800.00%-387.00K
-6500.00%-64.00K
140.00%2.00K
0.00%2.00K
-99.00%1.00K
-91.67%1.00K
50.00%-5.00K
--2.00K
--100.00K
1100.00%12.00K
-116.95%-10.00K
-100.00%0.00
--0.00
--1.00K
--59.00K
--53.00K
Income before tax
29.80%-7.79M
51.76%-3.98M
15.03%-8.72M
-6.11%-11.47M
18.46%-11.10M
9.72%-8.25M
6.31%-10.26M
19.08%-10.81M
27.21%-13.61M
55.06%-9.14M
20.07%-10.95M
15.60%-13.36M
-19.99%-18.70M
-53.12%-20.34M
-18.98%-13.70M
-38.78%-15.82M
-123.90%-15.59M
-193.01%-13.28M
-30.18%-11.51M
---11.40M
---6.96M
---4.53M
---8.85M
Income tax
--0.00
--0.00
----
----
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
29.80%-7.79M
51.76%-3.98M
15.03%-8.72M
-6.11%-11.47M
18.46%-11.10M
9.72%-8.25M
6.31%-10.26M
19.08%-10.81M
27.21%-13.61M
55.06%-9.14M
20.07%-10.95M
15.60%-13.36M
-19.99%-18.70M
-53.12%-20.34M
-18.98%-13.70M
-38.78%-15.82M
-123.90%-15.59M
-193.01%-13.28M
-30.18%-11.51M
---11.40M
---6.96M
---4.53M
---8.85M
Net income from continuous operations
29.80%-7.79M
51.76%-3.98M
15.03%-8.72M
-6.11%-11.47M
18.46%-11.10M
9.72%-8.25M
6.31%-10.26M
19.08%-10.81M
27.21%-13.61M
55.06%-9.14M
20.07%-10.95M
15.60%-13.36M
-19.99%-18.70M
-53.12%-20.34M
-18.98%-13.70M
-38.78%-15.82M
-123.90%-15.59M
-193.01%-13.28M
-30.18%-11.51M
---11.40M
---6.96M
---4.53M
---8.85M
Net income attributable to controlling interests
29.80%-7.79M
51.76%-3.98M
15.03%-8.72M
-6.11%-11.47M
18.46%-11.10M
9.72%-8.25M
6.31%-10.26M
19.08%-10.81M
27.21%-13.61M
55.06%-9.14M
20.07%-10.95M
15.60%-13.36M
-19.99%-18.70M
-53.12%-20.34M
-18.98%-13.70M
-38.78%-15.82M
-123.90%-15.59M
-193.01%-13.28M
-30.18%-11.51M
---11.40M
---6.96M
---4.53M
---8.85M
Net income attributable to common shareholders
29.80%-7.79M
51.76%-3.98M
15.03%-8.72M
-6.11%-11.47M
18.46%-11.10M
9.72%-8.25M
6.31%-10.26M
19.08%-10.81M
27.21%-13.61M
55.06%-9.14M
20.07%-10.95M
15.60%-13.36M
-19.99%-18.70M
-53.12%-20.34M
-18.98%-13.70M
-38.78%-15.82M
-123.90%-15.59M
-193.01%-13.28M
-30.18%-11.51M
---11.40M
---6.96M
---4.53M
---8.85M
Basic earnings per share
-965.43%-0.81
-783.36%-0.49
-1557.34%-1.16
-1740.22%-1.56
45.94%-0.08
43.53%-0.06
48.95%-0.07
50.04%-0.08
41.74%-0.14
72.02%-0.10
59.44%-0.14
57.81%-0.17
52.06%-0.24
28.01%-0.35
17.49%-0.34
1.92%-0.40
-91.72%-0.50
-187.62%-0.49
-21.84%-0.41
---0.41
---0.26
---0.17
---0.34
Diluted earnings per share
-965.43%-0.81
-783.36%-0.49
-1557.34%-1.16
-1740.22%-1.56
45.94%-0.08
43.53%-0.06
48.95%-0.07
50.04%-0.08
41.74%-0.14
72.02%-0.10
59.44%-0.14
57.81%-0.17
52.06%-0.24
28.01%-0.35
17.49%-0.34
1.92%-0.40
-91.72%-0.50
-187.62%-0.49
-21.84%-0.41
---0.41
---0.26
---0.17
---0.34
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Biodesix Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing BDSX stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Biodesix Inc's revenue at year end?

Biodesix Inc reported 88.50M in revenue for fiscal year 2025, up from 71.32M in the previous year.

How much revenue did Biodesix Inc report in the most recent quarter?

Biodesix Inc reported 25.55M in revenue for the most recent quarter, an increase of 42.30% year over year.

What was Biodesix Inc's net income for the year?

Biodesix Inc posted -35.27M in net income for fiscal year 2025.

How much net income did Biodesix Inc post in the last quarter?

Biodesix Inc reported -7.79M in net income for the latest quarter。

What was Biodesix Inc's annual operating profit?

Biodesix Inc's operating income was -27.77M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.